These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19387437)

  • 1. Mechanistic modeling of a magnetic marker monitoring study linking gastrointestinal tablet transit, in vivo drug release, and pharmacokinetics.
    Bergstrand M; Söderlind E; Weitschies W; Karlsson MO
    Clin Pharmacol Ther; 2009 Jul; 86(1):77-83. PubMed ID: 19387437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.
    Weitschies W; Blume H; Mönnikes H
    Eur J Pharm Biopharm; 2010 Jan; 74(1):93-101. PubMed ID: 19619649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.
    Hénin E; Bergstrand M; Standing JF; Karlsson MO
    AAPS J; 2012 Jun; 14(2):155-63. PubMed ID: 22286919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.
    Hénin E; Bergstrand M; Weitschies W; Karlsson MO
    Pharm Res; 2016 Mar; 33(3):751-62. PubMed ID: 26553354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
    Stevens HN; Speakman M
    Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AC biosusceptometry in the study of drug delivery.
    Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic markers as a noninvasive tool to monitor gastrointestinal transit.
    Weitschies W; Wedemeyer J; Stehr R; Trahms L
    IEEE Trans Biomed Eng; 1994 Feb; 41(2):192-5. PubMed ID: 8026852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
    Abrahamsson B; Edgar B; Lidman K; Wingstrand K
    Blood Press Suppl; 1993; 1():10-5. PubMed ID: 8173686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
    Chuong MC; Christensen JM; Ayres JW
    Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.
    Abrahamsson B; Alpsten M; Hugosson M; Jonsson UE; Sundgren M; Svenheden A; Tölli J
    Pharm Res; 1993 May; 10(5):709-14. PubMed ID: 8321836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms.
    Thelen K; Coboeken K; Willmann S; Dressman JB; Lippert J
    J Pharm Sci; 2012 Mar; 101(3):1267-80. PubMed ID: 22125236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic images of the disintegration process of tablets in the human stomach by ac biosusceptometry.
    Corá LA; Andreis U; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Phys Med Biol; 2005 Dec; 50(23):5523-34. PubMed ID: 16306649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.
    Varum FJ; Merchant HA; Basit AW
    Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations.
    Bergstrand M; Söderlind E; Eriksson UG; Weitschies W; Karlsson MO
    Pharm Res; 2012 Mar; 29(3):695-706. PubMed ID: 21948457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.